Tests for blood-fluid tumor markers are widely employed in cancer diagnosis, and several cancer biomarkers, including carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1), and neuron-specific enolase (NSE) [8–10], are used to diagnose lung cancer. Here, CEACAM5 is linked to lung cancer.